Sean P. Nolan, Chief Executive Officer at Taysha Gene Therapies, Inc. (TSHA), sold 178,101 shares at $4.61 ($840K) on 2026-01-26, disclosed to the SEC on 2026-01-27.
Open-market sale of $840k TSHA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.75 | 136,789 | $650K | 77.3% |
| 2 | $4.61 | 41,312 | $190K | 22.7% |
| Total | $4.72 avg | 178,101 | $840K | 100% |
| Filing → |
| AVXS | SELL | 2018-03-09 | $1.3M | — | Filing → |
| ITMN | SELL | 2014-08-14 | $850K | — | Filing → |
| ITMN | SELL | 2014-06-20 | $471K | — | Filing → |